| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 1,273,000 | 1,220,600 | 1,271,200 | 1,458,600 | | Cost of Revenue | 984,800 | 944,100 | 977,900 | 1,121,100 | | | Gross Profit | 288,200 | 276,500 | 293,300 | 337,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 229,800 | 235,200 | 236,400 | 286,800 | | Non Recurring |
-
| 100,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 58,400 | (58,700) | 56,900 | 50,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 700 | (3,300) | 600 | (16,700) | | Earnings Before Interest And Taxes | 59,100 | (62,000) | 57,500 | 34,000 | | Interest Expense | 17,400 | 17,300 | 14,500 | 13,400 | | Income Before Tax | 41,700 | (79,300) | 43,000 | 20,600 | | Income Tax Expense | 19,600 | 10,500 | 17,300 | 11,200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,100 | (89,800) | 25,700 | 9,400 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,100 | (89,800) | 25,700 | 9,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $22,100 | ($89,800) | $25,700 | $9,400 |
|
1.08% Nasdaq 
Income Statement
